MAPT and Alzheimer disease: Notably, the landmark cryo-EM study by Fitzpatrick et al. provided the first high-resolution structures of tau filaments extracted directly from human Alzheimer’s disease brain tissue, revealing disease-specific filament folds in patient-derived samples for the first time (Fitzpatrick et al., 2017).